Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease
Clinical trial NCT03077542 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03077542
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-06
- Primary completion
- 2023-07-27
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.